The AffiELISA® Human SDMA Kit uses competitive inhibition enzyme immunoassay technique. The provided microtiter plate comes pre-coated with Symmetric dimethylarginine (SDMA) protein. To perform the assay, standards or samples are added to designated wells on the microtiter plate. Subsequently, a biotin-conjugated antibody specific to Symmetric dimethylarginine (SDMA) is introduced. Avidin conjugated to Horseradish Peroxidase (HRP) is then added to each well, followed by an incubation period. Afterward, the TMB substrate solution is added, initiating an enzyme-substrate reaction. To conclude the reaction, a sulphuric acid solution is introduced, causing a color change that can be measured spectrophotometrically at a wavelength of 450nm ± 10nm. By comparing the optical density (OD) of the samples to the standard curve, the concentration of Symmetric dimethylarginine (SDMA) in the samples can be determined.
AffiELISA® Human SDMA Kit
Symmetric dimethylarginine
Symmetric dimethylarginine
Human
Competitive Inhibition ELISA
EDTA Plasma, Serum
Signal transduction, Developmental science, Bone metabolism.